Master of Pharmacy: Pharmacy Law and Ethics Flashcards
7 cards from real MPharm Master of Pharmacy practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 7 Master of Pharmacy: Pharmacy Law and Ethics flashcards as text
Under the Combat Methamphetamine Epidemic Act (CMEA), what is the daily purchase limit for pseudoephedrine products per customer?
Answer: 3.6 grams
CMEA limits pseudoephedrine purchases to 3.6 grams per day and 9 grams per 30-day period.
A pharmacist receives a prescription for a Schedule II controlled substance written 45 days ago. What is the correct action?
Answer: Refuse to fill it as Schedule II prescriptions must be filled within 30 days
Schedule II prescriptions must be filled within 30 days of the date written under federal DEA regulations.
Which ethical principle is MOST directly violated when a pharmacist discloses a patient's HIV status to a third party without consent?
Answer: Autonomy
Disclosing confidential health information without consent violates autonomy by overriding the patient's right to control their own information.
What is the primary purpose of the Orange Book (Approved Drug Products with Therapeutic Equivalence Evaluations)?
Answer: To identify drug products with therapeutic equivalence ratings for generic substitution
The Orange Book assigns therapeutic equivalence codes (e.g., AB) to guide safe generic drug substitution.
A DEA Form 222 is required for ordering which category of controlled substances?
Answer: Schedules I and II
DEA Form 222 (or CSOS electronic equivalent) is required to order Schedule I and II controlled substances.
Under HIPAA, which of the following is considered a permitted disclosure of Protected Health Information (PHI) without patient authorization?
Answer: Reporting communicable diseases to public health authorities
Public health reporting is a permitted HIPAA disclosure that does not require patient authorization.
The Poison Prevention Packaging Act (PPPA) requires child-resistant packaging for most prescription drugs. Which patient population can request non-child-resistant packaging?
Answer: Any patient or their physician upon request
Under the PPPA, any patient or their prescriber may request a waiver for non-child-resistant containers.